Merck Canada Puts $6.8M into AmorChem
Merck Canada has invested $6.8 million in AmorChem, a Quebec-based life sciences venture capital fund. The deal is Merck second Quebec-focused investment recently. Last month, the company poured $5 million into the Quebec Consortium for Drug Discovery, another group supporting early-stage biopharmaceutical research in Quebec.
18 February 2011•3 mins read
